A previous study has shown that ANRIL is associated with tumor size and advanced TNM stage in gastric cancer patients, and high ANRIL expression in gastric cancer tissues is associated with a poor prognosis (25). The gene discussed is CDKN2B-AS1; the disease is gastric cancer.